Cargando…
Inhibition of miR-222 by Oncolytic Adenovirus-Encoded miRNA Sponges Promotes Viral Oncolysis and Elicits Antitumor Effects in Pancreatic Cancer Models
SIMPLE SUMMARY: Oncolytic adenoviruses are replication-competent viruses engineered for use in cancer treatment. However, the transformation of cancer cells defines a scenario in which the viruses are not adapted to replicate. During tumorigenesis, a large number of miRNAs are deregulated, modulatin...
Autores principales: | Raimondi, Giulia, Gea-Sorlí, Sabrina, Otero-Mateo, Marc, Fillat, Cristina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267801/ https://www.ncbi.nlm.nih.gov/pubmed/34203557 http://dx.doi.org/10.3390/cancers13133233 |
Ejemplares similares
-
Late-phase miRNA-controlled oncolytic adenovirus for selective killing of cancer cells
por: Bofill-De Ros, Xavier, et al.
Publicado: (2015) -
Intratumoral delivery of a novel oncolytic adenovirus encoding human antibody against PD-1 elicits enhanced antitumor efficacy
por: Zhou, Ping, et al.
Publicado: (2022) -
Preclinical testing of oncolytic adenovirus sensitivity in patient-derived tumor organoids
por: Pascual-Sabater, Silvia, et al.
Publicado: (2021) -
Transgene codon usage drives viral fitness and therapeutic efficacy in oncolytic adenoviruses
por: Núñez-Manchón, Estela, et al.
Publicado: (2021) -
Expression of Oncolytic Adenovirus-Encoded RNAi Molecules Is Most Effective in a pri-miRNA Precursor Format
por: Brachtlova, Tereza, et al.
Publicado: (2020)